Since 2021, aggregated from related topics
Immune checkpoint blockade is a type of cancer immunotherapy that targets specific proteins on immune cells called checkpoints, which regulate the immune response. By blocking these checkpoints, the therapy allows the immune system to more effectively recognize and attack cancer cells. This approach has shown promising results in treating various types of cancer, including melanoma, lung cancer, and bladder cancer. Researchers continue to explore different combinations of checkpoint inhibitors and other treatments to enhance their effectiveness and extend their benefits to more patients.